Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

Boost, GPx will refine the accuracy of its debut product, CardioID, the world's first implant and needle-free remote blood monitoring solution for heart failure patients ... Sony Corporation, Jana ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...